Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Bogaards, JA"'
Current HPV vaccines target a subset of the oncogenic human papillomavirus (HPV) types. If HPV types compete during infection, vaccination may trigger replacement by the non-targeted types. Existing approaches to assess the risk of type replacement h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e662851fe66efc3ad186b4ebcefce95
https://doi.org/10.1101/523472
https://doi.org/10.1101/523472
Autor:
Brisson M, Bénard E, Drolet M, Bogaards JA, Baussano I, Vanska S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, De Vlas SJ, Guzzetta G, Hontelez JAC, Jepsen MR, Kim JJ, Lazzarato F, Mattijsse SM, Mikolajczyk R, Pavelyev A, Pillsbury M, Shafer LA, Tully SP, Turner HC, Usher C, Walsh C
Background Modelling studies have been widely used to inform human papillomavirus (HPV) vaccination policy decisions; however, many models exist and it is not known whether they produce consistent predictions of population-level effectiveness and her
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______293::aa8b2dcd4a894d5307ebd72e4c54b33e
https://hdl.handle.net/2123/30787
https://hdl.handle.net/2123/30787
Autor:
Woestenberg, PJ, King, AJ, van Benthem, BH, Donken, R, Leussink, S, van der Klis, FRM, de Melker, HE, van der Sande, M A J, Hoebe, CJ, Bogaards, JA, Adema, D, Buist-Arkema, R, Beerens, A, Luijt, D, Meijer, S, Schirm, J, Peeters, M, Rossen, JWA (John), Verbakel, H, Esch, PV, Verweij, J, Baltissen - van der Eijk, Annemiek, Huisman, RC, Kerkhof, C, Korff, MH, Schutten, M (Martin), Velzing, J, Verduyn-Lunel, F, Lakbiach, S, Rosmalen, PV, Schuurman, R (Rob), Abma, D, Adams, K, Bruisten, S, Linde, I, Oostvogel, P, Touwen, C, Vermeulen, W, Brink, A, Nelissen, J, Wolffs, P, Duijvendijk, N, Schneeberger, P, Poppel, MDV, Melchers, W, Poort, Y, Hooghiemstra, M, Huisman, H, Weel, J, Bosma, F, Geeraedts, F, Polman, I, Van Goor, P, Wolfhagen, M, De Mooij, C, Koolwijk, EV, Peters, M, Swanink, C, Tiemessen, R, Zwet, TV, Janssen, J, Pelsers, M, Waal, W, Aalfs, G, Kiewiet, J, Sanders, P, Buel-Bruins, HV, Bokhoven-Rombouts, CV, Cornelissen, P, Kersten, M, Ruitenbeek, CV, Molenaar, I, van Doorn, E, Masthoff, L, Pannekoek, E, Sigurdsson, V, Bugter, M, Götz, H, Linden, M, Mattijssen, M, Stam, J, Swaders, E, Groot, FD, Postma, F, Brouwers, E, Niekamp, A, Smit, M, Botraby, A, Bukasa, D, Haan, CD, Vliet, P, Taconis, T, Graas, MD, Hondelink, I, Kampman, C, Gelissen-Hansen, A, Koning, ID, Kruchten, HV, Pas, MVD, Fennema, H, Heijman, T, Hogewoning, A, Leeuwen, AV, Rooijen, MV, Neienhuijsen, F, Pelgrim, M
Publikováno v:
Journal of Infectious Diseases, 217(2), 213-222. Oxford University Press
Woestenberg, P J, King, A J, van Benthem, B H B, Donken, R, Leussink, S, van der Klis, F R M, de Melker, H E, van der Sande, M A B, Hoebe, C J P A, Bogaards, J A & Medical Microbiological Laboratories, and the Public Health Services 2018, ' Bivalent vaccine effectiveness against type-specific HPV positivity : evidence for cross-protection against oncogenic types among Dutch STI clinic visitors ', Journal of Infectious Diseases, vol. 217, no. 2, pp. 213-222 . https://doi.org/10.1093/infdis/jix582
The Journal of Infectious Diseases
The Journal of Infectious Diseases, 217(2), 213-222. Oxford University Press
Journal of Infectious Diseases, 217(2), 213. Oxford University Press
Woestenberg, P J, King, A J, van Benthem, B H B, Donken, R, Leussink, S, van der Klis, F R M, de Melker, H E, van der Sande, M A B, Hoebe, C J P A, Bogaards, J A & Medical Microbiological Laboratories, and the Public Health Services 2018, ' Bivalent vaccine effectiveness against type-specific HPV positivity : evidence for cross-protection against oncogenic types among Dutch STI clinic visitors ', Journal of Infectious Diseases, vol. 217, no. 2, pp. 213-222 . https://doi.org/10.1093/infdis/jix582
The Journal of Infectious Diseases
The Journal of Infectious Diseases, 217(2), 213-222. Oxford University Press
Journal of Infectious Diseases, 217(2), 213. Oxford University Press
In this cross-sectional study among vaccine-eligible female sexually transmitted infection clinic visitors, high vaccine effectiveness of the bivalent vaccine against the vaccine types HPV-16/18 was demonstrated and significant cross-protection again
Publikováno v:
Goudsmit, J, Bogaards, JA & Girard, M 2007, Cytotoxic T-Lymphocyte-Based Vaccines: Evidence for Efficacy in Animal Models and Humans . in AIDS Vaccine Development : Challenges and Opportunities . Caister Academic Press, pp. 23-28 .
AIDS Vaccine Development: Challenges and Opportunities, 23-28
STARTPAGE=23;ENDPAGE=28;TITLE=AIDS Vaccine Development
AIDS Vaccine Development: Challenges and Opportunities, 23-28
STARTPAGE=23;ENDPAGE=28;TITLE=AIDS Vaccine Development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::81ba822b21e4bb6ff2966155b5ca5f70
https://research.vumc.nl/en/publications/74d9bc46-ad99-4a8c-9d36-ac104196931c
https://research.vumc.nl/en/publications/74d9bc46-ad99-4a8c-9d36-ac104196931c
Publikováno v:
Tropical Medicine and International Health, 10(2 (Supplement)), A1-A9. Wiley-Blackwell
Bogaards, JA, Dijkgraaf, M G W, Weverling, G J, Goudsmit, J & Bossuyt, P M M 2005, ' Cost perspective of sustainable HIV treatment for developing countries ', Tropical Medicine and International Health, vol. 10, no. 2 (Supplement), pp. A1-A9 .
Bogaards, JA, Dijkgraaf, M G W, Weverling, G J, Goudsmit, J & Bossuyt, P M M 2005, ' Cost perspective of sustainable HIV treatment for developing countries ', Tropical Medicine and International Health, vol. 10, no. 2 (Supplement), pp. A1-A9 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::32c0cd55c2b08341481bb48c8c01d4d9
https://research.vumc.nl/en/publications/274b13f8-62cc-4f43-96af-d5959aa3d725
https://research.vumc.nl/en/publications/274b13f8-62cc-4f43-96af-d5959aa3d725
Publikováno v:
Hospital Pharmacy, 101(2), 4-9
Bogaards, JA, Dijkgraaf, M G W, Prins, JM & de Wolf, F 2004, ' Changing direct costs of HIV treatment since the introduction of HAART in the Netherlands ', Hospital Pharmacy, vol. 101, no. 2, pp. 4-9 .
Bogaards, JA, Dijkgraaf, M G W, Prins, JM & de Wolf, F 2004, ' Changing direct costs of HIV treatment since the introduction of HAART in the Netherlands ', Hospital Pharmacy, vol. 101, no. 2, pp. 4-9 .
Tremendous savings in hospital-based AIDS care have been reported over the first few years since HAART became widely available in 1996. However, longer term HAART may result in increasing costs, due to toxicity of antiretroviral regimens and developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c196d0bb5e3de924814d8fd1b4ff261b
https://research.vumc.nl/en/publications/295c0f18-4c34-4d0c-9b4c-b0ecbe617533
https://research.vumc.nl/en/publications/295c0f18-4c34-4d0c-9b4c-b0ecbe617533
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.